Humoral immunity to pertussis among mother-baby dyads

Introduction. Infants younger than 3 months old are at high risk of severe pertussis, complications and pertussis-associated mortality. Newborns receive protection against pertussis from maternal antibodies transferred predominantly during late pregnancy. Neither disease, nor vaccination provides li...

Full description

Saved in:
Bibliographic Details
Main Authors: O. V. Samodova, E. A. Krieger, V. G. Karamyan, N. L. Rogushina, K. P. Brovkova
Format: Article
Language:Russian
Published: Journal Infectology 2021-01-01
Series:Журнал инфектологии
Subjects:
Online Access:https://journal.niidi.ru/jofin/article/view/1146
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849241110378971136
author O. V. Samodova
E. A. Krieger
V. G. Karamyan
N. L. Rogushina
K. P. Brovkova
author_facet O. V. Samodova
E. A. Krieger
V. G. Karamyan
N. L. Rogushina
K. P. Brovkova
author_sort O. V. Samodova
collection DOAJ
description Introduction. Infants younger than 3 months old are at high risk of severe pertussis, complications and pertussis-associated mortality. Newborns receive protection against pertussis from maternal antibodies transferred predominantly during late pregnancy. Neither disease, nor vaccination provides lifelong immunity against pertussis. So most of women have low antibody concentrations, leaving their newborn infant at a higher risk for disease in the first months of life.The aim of this study was to assess the concentration of antibodies against Вordetella pertussis among mother-baby dyads.Methods. We performed a cross-sectional study including 119 mother-baby dyads. Maternal antibodies were measured in venous blood specimens during the last trimester of pregnancy for women and in cord blood for newborn infants.Results. The median age was 30 (25; 34) years. The half of participants had unknown vaccination status (49,6%). Only 12,6% had a protective level (>18 U/mL) of anti-pertussis antibodies, 74,8% of participants had a nonprotective (<14 U/mL) level and 12,6% had an equivocal (14–18 U/mL) antibody concentrations. All newborns of seropositive women and 11,5% infants of women with an equivocal titers receive protection against pertussis. Transplacental transport ratio of antibodies against pertussis was higher in newborns of seropositive women.Conclusion. We revealed a huge proportion of pregnant women (87,4%) and newborns (77,3%) susceptible to pertussis. Maternal antibody level against pertussis was the major predictor of the antibody level in the infant.
format Article
id doaj-art-61657144d00f45bb96ba12f37d9fbc75
institution Kabale University
issn 2072-6732
language Russian
publishDate 2021-01-01
publisher Journal Infectology
record_format Article
series Журнал инфектологии
spelling doaj-art-61657144d00f45bb96ba12f37d9fbc752025-08-20T04:00:18ZrusJournal InfectologyЖурнал инфектологии2072-67322021-01-01125727710.22625/2072-6732-2020-12-5-72-77868Humoral immunity to pertussis among mother-baby dyadsO. V. Samodova0E. A. Krieger1V. G. Karamyan2N. L. Rogushina3K. P. Brovkova4Northern State Medical UniversityNorthern State Medical UniversityArkhangelsk maternity hospital named after K.N. SamoylovaNorthern State Medical UniversityNorthern State Medical UniversityIntroduction. Infants younger than 3 months old are at high risk of severe pertussis, complications and pertussis-associated mortality. Newborns receive protection against pertussis from maternal antibodies transferred predominantly during late pregnancy. Neither disease, nor vaccination provides lifelong immunity against pertussis. So most of women have low antibody concentrations, leaving their newborn infant at a higher risk for disease in the first months of life.The aim of this study was to assess the concentration of antibodies against Вordetella pertussis among mother-baby dyads.Methods. We performed a cross-sectional study including 119 mother-baby dyads. Maternal antibodies were measured in venous blood specimens during the last trimester of pregnancy for women and in cord blood for newborn infants.Results. The median age was 30 (25; 34) years. The half of participants had unknown vaccination status (49,6%). Only 12,6% had a protective level (>18 U/mL) of anti-pertussis antibodies, 74,8% of participants had a nonprotective (<14 U/mL) level and 12,6% had an equivocal (14–18 U/mL) antibody concentrations. All newborns of seropositive women and 11,5% infants of women with an equivocal titers receive protection against pertussis. Transplacental transport ratio of antibodies against pertussis was higher in newborns of seropositive women.Conclusion. We revealed a huge proportion of pregnant women (87,4%) and newborns (77,3%) susceptible to pertussis. Maternal antibody level against pertussis was the major predictor of the antibody level in the infant.https://journal.niidi.ru/jofin/article/view/1146pertussisimmunitypregnant womeninfants
spellingShingle O. V. Samodova
E. A. Krieger
V. G. Karamyan
N. L. Rogushina
K. P. Brovkova
Humoral immunity to pertussis among mother-baby dyads
Журнал инфектологии
pertussis
immunity
pregnant women
infants
title Humoral immunity to pertussis among mother-baby dyads
title_full Humoral immunity to pertussis among mother-baby dyads
title_fullStr Humoral immunity to pertussis among mother-baby dyads
title_full_unstemmed Humoral immunity to pertussis among mother-baby dyads
title_short Humoral immunity to pertussis among mother-baby dyads
title_sort humoral immunity to pertussis among mother baby dyads
topic pertussis
immunity
pregnant women
infants
url https://journal.niidi.ru/jofin/article/view/1146
work_keys_str_mv AT ovsamodova humoralimmunitytopertussisamongmotherbabydyads
AT eakrieger humoralimmunitytopertussisamongmotherbabydyads
AT vgkaramyan humoralimmunitytopertussisamongmotherbabydyads
AT nlrogushina humoralimmunitytopertussisamongmotherbabydyads
AT kpbrovkova humoralimmunitytopertussisamongmotherbabydyads